FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 117 filers reported holding FULCRUM THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,835,490 | +29.1% | 5,818,804 | -4.0% | 0.54% | +43.0% |
| Q2 2023 | $20,011,606 | +27.4% | 6,064,123 | +10.0% | 0.38% | +16.5% |
| Q1 2023 | $15,708,741 | -56.8% | 5,511,839 | +10.4% | 0.33% | -55.9% |
| Q4 2022 | $36,351,071 | +12.7% | 4,993,279 | +25.3% | 0.74% | -0.1% |
| Q3 2022 | $32,246,000 | +66.1% | 3,985,910 | +0.6% | 0.74% | +48.3% |
| Q2 2022 | $19,410,000 | -77.3% | 3,961,194 | +9.7% | 0.50% | -71.7% |
| Q1 2022 | $85,405,000 | +24.9% | 3,611,194 | -6.6% | 1.77% | +77.0% |
| Q4 2021 | $68,405,000 | -37.1% | 3,866,872 | +0.3% | 1.00% | -39.1% |
| Q3 2021 | $108,758,000 | +223.8% | 3,855,291 | +20.3% | 1.64% | +223.5% |
| Q2 2021 | $33,591,000 | -11.0% | 3,205,291 | 0.0% | 0.51% | -13.9% |
| Q1 2021 | $37,758,000 | +55.7% | 3,205,291 | +54.7% | 0.59% | +44.7% |
| Q4 2020 | $24,256,000 | +165.8% | 2,071,409 | +80.0% | 0.41% | +85.0% |
| Q3 2020 | $9,124,000 | – | 1,150,565 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 3,962,202 | $19,415,000 | 7.94% |
| TRV GP IV, LLC | 2,343,154 | $11,481,000 | 7.55% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 949 | $193,741,000 | 2.02% |
| Logos Global Management LP | 1,950,000 | $9,555,000 | 1.75% |
| COWEN AND COMPANY, LLC | 2,385,885 | $11,691,000 | 1.13% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,355,624 | $16,443,000 | 0.62% |
| ACUTA CAPITAL PARTNERS, LLC | 200,000 | $980,000 | 0.55% |
| RTW INVESTMENTS, LP | 3,961,194 | $19,410,000 | 0.50% |
| Parkman Healthcare Partners LLC | 262,689 | $1,287,000 | 0.47% |
| Deep Track Capital, LP | 1,000,000 | $4,900,000 | 0.32% |